John Collins is a commercial litigation partner and leader of our national IP & Technology practice group, with over 30 years' experience in intellectual property and technology-related advice and dispute resolution.

He has a sophisticated understanding of all areas of intellectual property law with special expertise in innovation focused industries such as media and telecommunications. John's practice has also seen him work extensively on patent and trade mark systems in the Australian and international pharmaceutical markets. John also advises on Trade Practices Act issues including licensing, distribution, product issues, software and IT development and implementation.

Read More

Expertise

Expand all

Intellectual Property

Orion Corporation: Acting for Orion patent in infringement/revocation litigation against a generic pharmaceutical company and its related bodies corporate in relation to Novartis' product Stalevo. The matter involves multiple claims stemming from an Australian patent which has equivalents in other jurisdictions.  Analogous issues are also being litigated in Europe and in the US.
 

Novartis Pharma: Acting for Novartis Pharma AG and Novartis Pharmaceuticals Australia Pty Ltd in connection with enforcing patents which could potentially prevent the entry of generic competition for its blockbuster oncology drug Glivec (imatinib).

Novartis Pharma: Acting for Novartis in numerous patent infringement, validity disputes and revocation litigation including major four patent infringement/revocation litigations in relation to Novartis' products Zometa and Aclasta.

Telstra: Acting for Telstra in defending patent infringement litigation commenced by Upaid Systems Ltd in Federal Court.  Upaid Systems seeks to enforce two of these patents against Telstra across a broad range of pre- and post-paid products.

Sonic Healthcare: Acting for Sonic who are being sued in the Federal Court by Sequenom/Illumina for infringement of a patent for a method of non-invasive pregnancy testing.  This is a signal case as the equivalent patent has been held to be invalid in the USA on the basis of non-patentable subject matter.

Biomax Technologies Pte Ltd: Acting for Biomax Technologies, a Singaporean equipment manufacturer, the plaintiff in breach of confidence and copyright infringement proceedings. The litigation concerns the alleged copying of a machine known as the Rapid Thermophilic Digestor. The case involves ground-breaking copyright authorisation issues. Parallel proceedings are being conducted in Singapore.

Amgen: Acted for Amgen in defending patent revocation proceedings brought by Hospira concerning patent related to its white blood cell harvesting drug Neulasta (pegfilgrastim).

Herschel: Assisting Herschel develop and implement anti-counterfeiting program for its iconic backpacks.

Eli Lilly & Company: Represented Eli Lilly in connection with patent infringement and revocation proceedings for its gemcitabine hydrochloride molecule which forms the basis of its successful anti-cancer treatment GEMZAR.

Confidential client:
 Acted for the local subsidiary of a major Chinese corporation in determining trade secret and copyright claims brought by a competitor in relation to grinding mills.

Redberry Enterprises:
Acted for Redberry Enterprises Pty Ltd in the first Australian court decision to consider in detail the new infringement test under the Designs Act 2003.

Sandoz:
Represented Sandoz in proceedings concerning formulation patents for the gastric reflux molecule omeprazole.

Asea Brown Boveri:
Advised on a number of mechanical patent matters concerning machinery and components in relation to air conditioning systems and ducting for power stations.

Ludowici Limited:
Advised on patent and copyright infringement issues concerning mineral processing equipment.

Go Talk Australia Pty Ltd:
Acted in patent infringement action brought in the Federal Court of Australia against Answer Pre Paid Pty Ltd and Alpha Telecom Pty Ltd for infringement of an Innovation Patent directed to a real time pre-paid call access system.

See Intellectual Property

Telecommunications, Media and Technology

Telstra: Acting for Telstra in defending patent infringement litigation commenced by Upaid Systems Ltd in Federal Court.  Upaid Systems seeks to enforce two of these patents against Telstra across a broad range of pre- and post-paid products.  This matter is one of the major patent cases before the Australia courts.

nbn: Assists nbn across a range of technology-related issues.

Apple: Advised Apple on a range of intellectual property and consumer protection related issues concerning iPad and iPhone products.

Intel: Acted for Intel in relation to a discrete issue in the Apple/Samsung patent litigation.

QBE: Advised QBE in connection with a dispute concerning the implementation of a new computer system for CTP insurance in South Australia.

MicroFocus: Acted for terminal emulation software provider MicroFocus Ltd in copyright infringement proceedings brought against NSW Police Force.

Singtel Optus:  Acted for Optus in the High Court dispute with Telstra and the ACCC concerning the constitutional basis of the ACCC's power to regulate telecommunications in Australia.

Singtel Optus: Acted for Optus in a number of disputes concerning resale of audiotext traffic across various networks into Australia.

AAPT:
 Acted for AAPT Limited in relation to telecommunications claims concerning Telstra's billing platforms including trade practices and misuse of market power claims.

Go Talk Australia Pty Ltd: Acted in a patent infringement action brought in the Federal Court of Australia against Answer Pre Paid Pty Ltd and Alpha Telecom Pty Ltd for infringement of an Innovation Patent directed to a real time pre-paid call access system.

See Telecommunications, Media and Technology

Litigation and Dispute Resolution

Orion Corporation: Acting for Orion patent in infringement/revocation litigation against a generic pharmaceutical company and its related bodies corporate in relation to Novartis' product Stalevo. The matter involves multiple claims stemming from an Australian patent which has equivalents in other jurisdictions.  Analogous issues are also being litigated in Europe and in the US.

Novartis Pharma: Acting for Novartis Pharma AG and Novartis Pharmaceuticals Australia Pty Ltd in connection with enforcing patents which could potentially prevent the entry of generic competition for its blockbuster oncology drug Glivec (imatinib).

Novartis Pharma: Acting for Novartis in numerous patent infringement, validity disputes and revocation litigation including major four patent infringement/revocation litigations in relation to Novartis' products Zometa and Aclasta.

Barangaroo Delivery Authority: Advised on numerous issues including in relation to a complex dispute concerning Barangaroo South and Lend Lease in proceedings heard in the NSW Supreme Court.

MicroFocus: Acted for terminal emulation software provider MicroFocus Ltd in copyright infringement proceedings brought against NSW Police Force.

Amgen: Acted for Amgen in defending patent revocation proceedings brought by Hospira concerning patent related to its white blood cell harvesting drug Neulasta (pegfilgrastim).

Eli Lilly & Company:  Acting for Eli Lilly in connection with patent infringement and revocation proceedings for its gemcitabine hydrochloride molecule which forms the basis of its successful anti-cancer treatment GEMZAR.

Confidential client:  Acting for the local subsidiary of a major Chinese corporation in determining trade secret and copyright claims brought by a competitor in relation to grinding mills.

AstraZeneca Pty Ltd:
Advised AstraZeneca on the appropriate patents to be referenced under Pharmaceutical Benefits Scheme Reforms.

Singtel Optus:
  Successfully acted for Optus in the High Court dispute with Telstra and the ACCC concerning the constitutional basis of the ACCC's power to regulate telecommunications in Australia.

Redberry Enterprises Pty Ltd:
Successfully acted for Redberry Enterprises Pty Ltd in the first Australian court decision to consider in detail the new infringement test under the Designs Act 2003 (Cth).

Sandoz (formerly Biochemie):
Successfully represented Sandoz in proceedings concerning formulation patents for the gastric reflux molecule omeprazole.

AAPT:
 Acted for AAPT Limited in relation to telecommunications claims concerning Telstra's billing platforms including trade practices and misuse of market power claims.

Go Talk Australia Pty Ltd:
  Acted in a patent infringement action brought in the Federal Court of Australia against Answer Pre Paid Pty Ltd and Alpha Telecom Pty Ltd for infringement of an Innovation Patent directed to a real time pre-paid call access system.

See Litigation and Dispute Resolution

Patents

Orion Corporation: Acting for Orion patent in infringement/revocation litigation against a generic pharmaceutical company and its related bodies corporate in relation to Novartis' product Stalevo. The matter involves multiple claims stemming from an Australian patent which has equivalents in other jurisdictions.  Analogous issues are also being litigated in Europe and in the US.

Novartis Pharma: Acting for Novartis Pharma AG and Novartis Pharmaceuticals Australia Pty Ltd in connection with enforcing patents which could potentially prevent the entry of generic competition for its blockbuster oncology drug Glivec (imatinib).

Novartis Pharma: Acting for Novartis in numerous patent infringement, validity disputes and revocation litigation including major four patent infringement/revocation litigations in relation to Novartis' products Zometa and Aclasta.

Telstra: Acting for Telstra in defending patent infringement litigation commenced by Upaid Systems Ltd in Federal Court before Yates J.  Upaid Systems is a non-practising entity which acquired communications technology-related patents. It seeks to enforce two of these patents against Telstra across a broad range of pre- and post-paid products.  This matter is one of the major patent cases before the Australia courts.

Sonic Healthcare: Advising Sonic who are being sued in the Federal Court in Melbourne by Sequenom/Illumina for infringement of a patent for a method of non-invasive pregnancy testing.  This is a signal case as the equivalent patent has been held to be invalid in the USA on the basis of non-patentable subject matter.

Biomax Technologies Pte Ltd: Acting for Biomax Technologies, a Singaporean equipment manufacturer, the plaintiff in breach of confidence and copyright infringement proceedings. The litigation concerns the alleged copying of a machine known as the Rapid Thermophilic Digestor. The case involves ground-breaking copyright authorisation issues. Parallel proceedings are being conducted in Singapore.

Amgen: Acted for Amgen in defending patent revocation proceedings brought by Hospira concerning patent related to its white blood cell harvesting drug Neulasta (pegfilgrastim).

Eli Lilly & Company: Acting for Eli Lilly in connection with patent infringement and revocation proceedings for its gemcitabine hydrochloride molecule which forms the basis of its successful anti-cancer treatment GEMZAR.

AstraZeneca Pty Ltd:
Advised AstraZeneca on the appropriate patents to be referenced under Pharmaceutical Benefits Scheme Reforms.

Sandoz:
Successfully represented Sandoz in proceedings concerning formulation patents for the gastric reflux molecule omeprazole.

Asea Brown Boveri:
 Advising on a number of mechanical patent matters concerning machinery and components in relation to air conditioning systems and ducting for power stations.

Ludowici Limited:
 Advised on patent and copyright infringement issues concerning mineral processing equipment.

Go Talk Australia Pty Ltd:
Acted in a patent infringement action brought in the Federal Court of Australia against Answer Pre Paid Pty Ltd and Alpha Telecom Pty Ltd for infringement of an Innovation Patent directed to a real time pre-paid call access system.

See Patents

Trade Marks

Confidential client: Acted for the local subsidiary of a major Chinese corporation in determining trade secret and copyright claims brought by a competitor in relation to grinding mills.

Herschel: Assisting Herschel develop and implement anti-counterfeiting program for its iconic backpacks.

Woolworths Limited: Advised on trade name and branding issues in a dispute with Nine Network and ACP.

See Trade Marks

Copyright

Biomax Technologies Pte Ltd: Acting for Biomax Technologies, a Singaporean equipment manufacturer, the plaintiff in breach of confidence and copyright infringement proceedings. The litigation concerns the alleged copying of a machine known as the Rapid Thermophilic Digestor. The case involves ground-breaking copyright authorisation issues. Parallel proceedings are being conducted in Singapore.

MicroFocus: Acted for terminal emulation software provider MicroFocus Ltd in copyright infringement proceedings brought against NSW Police Force.

Barangaroo Delivery Authority: Advised the Authority on unauthorised use by Wilson Property Agents of various images and logos on the website www.barangarooresidential.net.au. This included advice on copyright infringement and passing off.

Confidential client: Acted for the local subsidiary of a major Chinese corporation in determining trade secret and copyright claims brought by a competitor in relation to grinding mills.

Ludowici Limited: Advised on copyright infringement issues concerning mineral processing equipment.

See Copyright

Pharmaceutical and Medical Devices

Eli Lilly & Company: Acted for Eli Lilly in connection with patent infringement and revocation proceedings for its gemcitabine hydrochloride molecule which forms the basis of its successful anti-cancer treatment GEMZAR.

AstraZeneca Pty Ltd:
Advised AstraZeneca on the appropriate patents to be referenced under the new Pharmaceutical Benefits Scheme Reforms.

Sandoz:
Represented Sandoz in proceedings concerning formulation patents for the gastric reflux molecule omeprazole.

Orion Corporation: Acting for Orion patent in infringement/revocation litigation against a generic pharmaceutical company and its related bodies corporate in relation to Novartis' product Stalevo. The matter involves multiple claims stemming from an Australian patent which has equivalents in other jurisdictions.  Analogous issues are also being litigated in Europe and in the US.

Novartis Pharma: Acting for Novartis Pharma AG and Novartis Pharmaceuticals Australia Pty Ltd in connection with enforcing patents which could potentially prevent the entry of generic competition for its blockbuster oncology drug Glivec (imatinib).

Novartis Pharma: Acting for Novartis in numerous patent infringement, validity disputes and revocation litigation including major four patent infringement/revocation litigations in relation to Novartis' products Zometa and Aclasta.

Telstra: Acting for Telstra in defending patent infringement litigation commenced by Upaid Systems Ltd in Federal Court.  Upaid Systems seeks to enforce two of these patents against Telstra across a broad range of pre- and post-paid products.

Sonic Healthcare: Acting for Sonic who are being sued in the Federal Court by Sequenom/Illumina for infringement of a patent for a method of non-invasive pregnancy testing.  This is a signal case as the equivalent patent has been held to be invalid in the USA on the basis of non-patentable subject matter.

Biomax Technologies: Acting for Biomax Technologies, a Singaporean equipment manufacturer, the plaintiff in breach of confidence and copyright infringement proceedings. The litigation concerns the alleged copying of a machine known as the Rapid Thermophilic Digestor. The case involves ground-breaking copyright authorisation issues. Parallel proceedings are being conducted in Singapore.

Amgen: Acted for Amgen in defending patent revocation proceedings brought by Hospira concerning patent related to its white blood cell harvesting drug Neulasta (pegfilgrastim).

See Pharmaceutical and Medical Devices

Knowledge

    Related knowledge information is loading